ordinary shares of Modern Pharma Company Limited is a subsidiary of the Company, the Company, therefore, has a duty to disclose the transaction information of the Company to the Stock Exchange of Thailand
months which considered as disposition of assets category 2 as size of transaction more than 15% but less than 50% by CEN need to prepare and promptly disclose information to The Stock Exchange of Thailand
Kewkacha and (2) Mr. Thana Kewkacha, who had resigned, respectively. The appointment was in effect from August 27, 2019. Consequently, the Company is obliged to disclose the information memorandum in
Equity Capacity COD of projects Selective Growth COD of projects ERU +250MW Rayong WTE +10MW Expansion+18MW +2,771MW COD of projects CUP 4 +45MW NL1PC +26MW CUP 3 Expansion +15MW XPCL +321MW +39.5MW Note
and Wind) FUTURE GROWTH Inorganic Growth 4,748 MW Equity Capacity 4,766 MW Equity Capacity 5,026 MW Equity Capacity COD of projects4,776 MW Equity Capacity COD of projects Selective Growth COD of
equivalent to 15 percent or higher, but lower than 50 percent in accordance with the Notifications on Acquisition or Disposal. As a result, the Company is required to disclose an information memorandum on the
When an intermediary has already entered into the transaction as prescribed in Clause 22, it shall disclose adequately and appropriately such transaction to a client or a representative of the client
(collectively as the “Tender Offer Preparers”). In this regard, the Tender Offeror would like to disclose additional information on the Tender Offer for the Securities of the Business hereto. Yours Sincerely